Rapid Micro Biosystems Inc (RPID)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $32.65M
Last updated: Nov 17, 2026 at 11:05 AM ET
Rapid Micro Biosystems Inc (RPID) Stock Forecast
Analysts expect Rapid Micro Biosystems (RPID) to earn -$0.94 per share in the fiscal year ending Dec 31, 2026, on revenue of $39.28M. Of 5 analysts, 5 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 2 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 5 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 5 | 100.0% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 5
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 17.9%.
- Fiscal year ending Dec 31, 2026
- -$0.94
- EPS consensus, revenue $39.28M
- Fiscal year ending Dec 31, 2027
- -$0.72
- EPS consensus, revenue $46.32M
- Next report
- Mar 10, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.94 | -$0.96 to -$0.91 | 4 | $39.28M | $38.50M to $40.70M | 5 |
| Dec 31, 2027 | -$0.72 | -$0.77 to -$0.65 | 4 | $46.32M | $44.00M to $49.00M | 5 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.16 | -$0.18 to -$0.14 | 5 | $13.64M | $12.05M to $15.86M | 6 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 3 upward and 3 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 2 |
| Fiscal year ending Dec 31, 2027 | 2 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$0.93.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.94 | -$0.94 | -$0.94 | -$0.93 | -$0.93 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.72 | -$0.73 | -$0.73 | -$0.79 | -$0.79 | N/A |
Frequently Asked Questions About RPID
What is the RPID stock forecast?
Consensus analyst estimates put Rapid Micro Biosystems's EPS at -$0.94 for the fiscal year ending Dec 31, 2026, on revenue of $39.28M. The consensus rating from 5 analysts is Buy.
How do analysts rate RPID stock?
Of 5 analysts covering Rapid Micro Biosystems, 0 rate it Strong Buy, 5 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from RPID next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.94, with estimates from -$0.96 to -$0.91 from 4 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.72, with estimates from -$0.77 to -$0.65 from 4 analysts.
What revenue do analysts expect from Rapid Micro Biosystems next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $39.28M, with estimates from $38.50M to $40.70M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $46.32M, with estimates from $44.00M to $49.00M.
How many analysts cover RPID?
5 analysts rate Rapid Micro Biosystems stock, and 4 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
RPID pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts